Request that the FDA declare that the proposed drug product, Levetiracetam Powder for Oral Solution, 250 mg/ sachet, 500 mg/sachet, 750 mg/sachet, 1,000 mg/sachet and 1500 mg/sachet are suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2026-P-5876
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.